The Hôpital Albert Schweitzer was established in 1913 by Albert Schweitzer and Helene Bresslau Schweitzer in Lambaréné, Gabon.

There are 150 beds in Medical Research Unit, Albert Schweitzer Hospital.

During the past decade, Medical Research Unit, Albert Schweitzer Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Research Unit, Albert Schweitzer Hospital" #1 sponsor was "Albert Schweitzer Hospital" with 7 trials, followed by "Medicines for Malaria Venture" with 3 trials sponsored, "African Malaria Network Trust" with 2 trials sponsored, "Centre de Recherche Médicale de Lambaréné" with 2 trials sponsored and "Baylor College of Medicine" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Research Unit, Albert Schweitzer Hospital" #1 collaborator was "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 2 trials as a collaborator, "Shin Poong Pharmaceuticals" with 2 trials as a collaborator, "Albert Schweitzer Hospital" with 1 trials as a collaborator and "Armauer Hansen Research Institute, Ethiopia" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Medical Research Unit, Albert Schweitzer Hospital" are "Malaria" (10 trials), "Uncomplicated Plasmodium Falciparum Malaria" (2 trials), "Africa" (1 trials), "Coronavirus Infection" (1 trials) and "Drug Resistance" (1 trials). Many other conditions were trialed in "Medical Research Unit, Albert Schweitzer Hospital" in a lesser frequency.

Most popular intervention types in "Medical Research Unit, Albert Schweitzer Hospital" are "Drug" (13 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "ART only arm" (1 trials), "Artefenomel 800mg: piperaquine 1440mg" (1 trials), "Artefenomel 800mg: piperaquine 640mg" (1 trials), "Artefenomel 800mg: piperaquine 960mg" (1 trials) and "Artesunate-Mefloquine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Research Unit, Albert Schweitzer Hospital" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medical Research Unit, Albert Schweitzer Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Medical Research Unit, Albert Schweitzer Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Research Unit, Albert Schweitzer Hospital, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".